Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Radiology|July 10, 2012
Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imagingValencia King, Shari B Goldfarb, Jennifer D Brooks, et al.
Cancers|December 1, 2020
Contrast-Enhanced Mammography for Screening Women after Breast Conserving SurgeryJill Gluskin, Carolina Rossi Saccarelli, Daly Avendano, et al.
Breast Cancer Research and Treatment|February 8, 2023
Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatmentMolly P Hogan, Joao V Horvat, Dara S Ross, et al.
Radiology|February 11, 2025
Hormonal Regulation of Background Parenchymal Enhancement at Contrast-enhanced MammographyNoam Nissan, Varadan Sevilimedu, Jill Gluskin, et al.
European Journal of Radiology|December 14, 2024
Non-enhancing asymmetries on screening contrast-enhanced mammography: Is further diagnostic workup required?Noam Nissan, Jeffrey S Reiner, Victoria L Mango, et al.
European Journal of Radiology|November 22, 2024
Extremely dense breasts: A comprehensive review of increased cancer risk and supplementary screening methodsNoam Nissan, Rosa Elena Ochoa Albiztegui, Hila Fruchtman-Brot, et al.
European Journal of Radiology|May 21, 2013
Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsyJanice S Sung, Valencia King, Cynthia M Thornton, et al.
European Journal of Radiology|November 20, 2025
Longitudinal fluctuations in reported background parenchymal enhancement on contrast enhanced mammographyNoam Nissan, Jeffrey S Reiner, Yuki Arita, et al.
Radiology|August 28, 2019
Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast CancerJanice S Sung, Lizza Lebron, Delia Keating, et al.
Radiology. Imaging Cancer|May 1, 2026
Interval Cancers after Negative Screening Contrast-enhanced MammographyTali Amir, Carol H Lee, Sarah Eskreis-Winkler, et al.
Pageof 7